The Role of Platelets in Diabetic Kidney Disease

Ukhti Jamil Rustiasari, Joris J. Roelofs

Research output: Contribution to journalReview articleAcademicpeer-review

10 Citations (Scopus)


Diabetic kidney disease (DKD) is among the most common microvascular complications in patients with diabetes, and it currently accounts for the majority of end-stage kidney disease cases worldwide. The pathogenesis of DKD is complex and multifactorial, including systemic and intra-renal inflammatory and coagulation processes. Activated platelets play a pivotal role in inflammation, coagulation, and fibrosis. Mounting evidence shows that platelets play a role in the pathogenesis and progression of DKD. The potentially beneficial effects of antiplatelet agents in preventing progression of DKD has been studied in animal models and clinical trials. This review summarizes the current knowledge on the role of platelets in DKD, including the potential therapeutic effects of antiplatelet therapies.
Original languageEnglish
Article number8270
JournalInternational journal of molecular sciences
Issue number15
Publication statusPublished - Aug 2022


  • antiplatelet
  • biomarker
  • diabetes
  • diabetic kidney disease
  • diabetic nephropathy
  • platelet activation
  • platelets

Cite this